Compare AU

Compare CURE vs. F100

Compare shares and ETFs on the ASX that you can trade on Pearler.

Global X S&P Biotech ETF

ASX

Buy

Buy

Overview
Industry & Region

Industry & Region


Country Exposure

CURE

F100

United States

97.17 %

0.96 %

Switzerland

1.51 %

2.89 %

United Kingdom of Great Britain and Northern Ireland

1.16 %

95.85 %

Ireland

0.16 %

0.00 %

Mexico

0.06 %

Netherlands

0.05 %

China

0.04 %

Brazil

0.03 %

Italy

0.02 %

Japan

0.02 %

Canada

0.01 %

France

0.01 %

Sweden

0.01 %

Germany

0.01 %

Taiwan

0.01 %

India

0.01 %

Israel

0.00 %

Denmark

0.00 %

Spain

0.00 %

Greece

0.00 %

Hong Kong

0.00 %

Indonesia

0.00 %

Australia

0.00 %

Korea

0.00 %

Malaysia

0.00 %

Norway

0.00 %

Portugal

0.00 %

Singapore

0.00 %

Turkey

0.00 %


Industry Exposure

icon for key differences panel

Key differences

  • CURE has a higher allocation (100.00 %) in the Health Care sector than F100 (11.91 %).

  • The most popular industries that CURE is exposed to are Health Care (100.00 %), and Other (10.24 %). Comparatively, F100 is most exposed to Financials (17.65 %), Consumer Staples (17.44 %), and Energy (13.29 %).

CURE

F100

Health Care

100.00 %

11.91 %

Other

10.24 %

2.62 %

Financials

17.65 %

Consumer Staples

17.44 %

Energy

13.29 %

Industrials

12.14 %

Materials

9.17 %

Consumer Discretionary

6.87 %

Utilities

4.18 %

Communication Services

2.76 %

Information Technology

1.03 %

Real Estate

0.94 %

Home